文献速递免疫规划卫生政策与健康促进

瑞士学龄前儿童国家推荐疫苗接种的覆盖率与及时性:基于理赔数据的描述性分析

Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data.
PubMed 文献 · Vaccine · 2019-11-30

基于瑞士大型健康保险公司Helsana的理赔数据,对2010年1月至2016年12月出生的563,216名儿童进行描述性分析。结果显示37月龄时基础疫苗首剂覆盖率较高(DTaP 95.4%、Hib 94.9%、IPV 95.5%、MMR 86.8%),但完成基础疫苗全程仅约七成,补充疫苗(PCV 83.2%、MCV 66.7%)全程仅约六成,4%儿童未接种任何推荐疫苗,且延迟接种常见(MMR首剂延迟22.6%)。

要点

  • 37月龄时基础疫苗首剂覆盖率DTaP 95.4%、Hib 94.9%、IPV 95.5%、MMR 86.8%。
  • 完成基础疫苗全程仅约七成,补充疫苗全程仅约六成(PCV 83.2%、MCV 66.7%)。
  • 4%儿童未接种任何推荐疫苗,MMR首剂延迟接种占22.6%。

核心结论

  • 为避免未来疫苗可预防疾病的暴发和传播,瑞士的疫苗接种覆盖率必须进一步提高,并应更重视及时接种。

研究设计与样本

  • 基于瑞士大型健康保险公司Helsana的行政理赔数据,对2010年1月至2016年12月出生的儿童队列进行描述性研究,共纳入563,216名儿童,分析13、25、37月龄的接种覆盖率及及时性,并将结果外推至瑞士人口。

主要发现

  • 37月龄时研究疫苗首剂的最新状态:DTaP 95.4%、Hib 94.9%、IPV 95.5%、MMR 86.8%、PCV 83.2%、MCV 66.7%。
  • 平均仅十分之七的儿童完成基础疫苗接种的最新状态,十分之六的儿童完成推荐补充疫苗接种的最新状态。
  • 4%的分析儿童未接种任何推荐疫苗,且存在显著地区差异。
  • 疫苗延迟接种常见,MMR首剂接种延迟相对于适龄标准的比例为22.6%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low vaccination coverage as well as incomplete and delayed vaccinations pose a risk for the individual and population protection from vaccine-preventable diseases. AIM: To describe vaccination patterns for nationally recommended basic and supplementary vaccinations in Swiss preschool children. METHODS: We performed a descriptive study based on administrative claims data from a large Swiss health insurer (Helsana), in cohorts of children born between January 2010 and December 2016. We assessed coverage rates of nationally recommended basic vaccinations (i.e., diphtheria, tetanus, acellular pertussis [DTaP], Haemophilus influenzae type b [Hib], poliomyelitis [IPV], measles, mumps, and rubella [MMR]) and supplementary vaccinations (i.e., pneumococcal conjugate vaccine [PCV] and meningococcal group C conjugate vaccine [MCV]) for each birth cohort at the age of 13, 25, and 37 months. Additionally, we analysed timeliness of vaccinations using inverse Kaplan-Meier curves. Results were extrapolated to the Swiss population. RESULTS: The study population comprised 563,216 children. We observed continuously increasing coverage rates for all vaccinations until the 2015 birth cohort. Overall, up-to-date status for the first dose of studied vaccinations at 37 months was as follows: DTaP: 95.4%; Hib: 94.9%; IPV: 95.5%; MMR: 86.8%; PCV: 83.2%; and MCV: 66.7%. On average, however, only seven out of ten children had an up-to-date status for completed basic vaccinations; even less (six out of ten) were up-to-date for recommended supplementary vaccinations at 37 months of age. Moreover, 4% of all analysed children received none of the recommended vaccinations and there were substantial regional differences. Delays in vaccine administration were common. The most frequently postponed basic vaccination was MMR; 22.6% of children vaccinated with the first dose experienced delays relative to age-appropriate standards. CONCLUSION: To avoid future outbreaks and transmission of vaccine-preventable diseases, vaccination coverage in Switzerland must be further improved. In addition, more emphasis should be placed on timely vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Schneider R, Reinau D, Schur N, et al. Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data. Vaccine. 2019. PMID: 31791812. doi:10.1016/j.vaccine.2019.11.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。